Tirzepatide / BPC-157 (Peplogix)

Product Description
Tirzepatide / BPC-157 Blend Research Peptide
Size: Lyophilized Vial (31.3mg, 62.6mg)
Purity: >99% (Third-Party Tested)
Documentation: Batch-specific Certificate of Analysis (COA) available for every lot.

Product Overview
This lyophilized blend combines Tirzepatide, a dual GLP-1 and GIP receptor agonist, with BPC-157, a pentadecapeptide widely studied in tissue-repair and gastrointestinal research. It is intended for in-vitro and laboratory research into metabolic and regeneration pathways.

Every vial is manufactured under strict quality-control standards and independently verified by accredited third-party laboratories. A batch-specific Certificate of Analysis (COA) accompanies every order to confirm purity, molecular identity, and batch-to-batch consistency.

Key Features & Research Profiles
Metabolic and Tissue Repair Research Focus: A dual-pathway blend spanning incretin signaling and tissue-repair research.
Rigorous Synthesis Controls: Produced under strict protocols to limit variables and support reproducible experimental data.
Accredited Verification: Full transparency with independent, third-party testing and batch-specific reporting.

Specifications & Handling
Application: For research use only. Not for human consumption.
Storage: Store at -20°C upon receipt. Protect from light and moisture. The lyophilized format maintains structural stability at room temperature for brief transit windows.